Enhancing Pharmacist Involvement in Care in Medically Assisted Treatment for Opioid Dependence (EPIC-MATOD) Project

Enhancing Pharmacist Involvement in Care in Medically Assisted Treatment for Opioid Dependence (EPIC-MATOD) Project

Action Area

Improving service access for people with opioid dependence

Strategic Direction

Local Solutions

Priority Actions

Access to better connected care; supporting better, safer care

Target Population

Pharmacists that provide pharmacotherapy services to people in need of opioid substitution treatment

Summary

The Enhancing Pharmacist Involvement in Care (EPIC)-MATOD project is a four-phased project. In the first phase, a model of care was co-designed with project partners to improve treatment access & capacity by using community pharmacists at their full scope of practice, in collaboration with MATOD prescribers, in areas where access to prescribers is poor.

The project has been funded to implement and evaluate the model of care with patients at a number of MATOD pharmacies in the Frankston Mornington Peninsula (FMP) region (phase 2 & 3). The implementation study aims to determine whether a collaborative model improves treatment access and retention, identify factors important for successful implementation, and determine the cost per patient of delivering the model of care. Findings will help identify the resources and strategies needed for a phase 4, which will involve scaling up the collaborative model of care to other geographic areas with similar needs to expand access to MATOD.

The project is led by the Monash Addiction Research Centre and Frankston Mornington Primary Care Partnership’s RAD-FMP initiative (under the auspice of Peninsula Health), in collaboration with local and state government and peak professional and consumer organisations.

The EPIC MATOD Implementation Study received funding from the Alcohol and Drug Research Innovation Agenda (ADRIA), a Victorian Government initiative. ADRIA is administered by the Victorian Alcohol and Drug Association (VAADA). For more information about the study see: https://www.monash.edu/medicine/ehcs/marc/research/current/EPIC-MATOD

Project Partners: A collaboration between MARC, Frankston Mornington Peninsula Primary Care Partnership (under the auspice of Peninsula Health), Pharmaceutical Society of Australia, Royal Australian College of General Practitioners, Harm Reduction Victoria, Pharmacy Guild, Australian Medical Association, Area 4 Pharmacotherapy Network and Frankston Council.

Contact: For any information about this initiative, please contact Kirsty Morgan, Alcohol and other Drugs Project Coordinator, KMorgan@phcn.vic.gov.au .